AstraZeneca rejects new Pfizer bid
UK drugs company AstraZeneca has rejected an improved "final" takeover offer from US drugs giant Pfizer.
Pfizer had made a new offer of £55 per share, valuing AstraZeneca at about £69bn.
The BBC's Steph McGovern reports.
19 May 2014
- From the section Business